Treatment of unruptured small and medium-sized wide necked aneurysms using the 64-wire Surpass Evolve: A subanalysis from the SEASE International Registry

Authors

Affiliations

Brain & Spine Institute, Park Ridge

Abstract

Background: Flow diversion has revolutionized the management of wide-necked intracranial aneurysms (IAs). We aimed to assess the effectiveness and safety of the new generation 64-wire Surpass Evolve for the treatment of unruptured small/medium-sized IAs.

Methods and results: This is a subanalysis from the SEASE (Safety and Effectiveness Assessment of the Surpass Evolve) registry, an observational cohort study including 15 academic institutions in North America and Europe between July 2020 and October 2022. Patients with wide-necked saccular IAs, measuringP=0.03).

Conclusions: Patients with small/medium-sized IAs can be effectively treated using the Surpass Evolve, a new generation, 64-wire, cobalt-chromium flow diverter.

Document Type

Article

PubMed ID

39450745


 

Share

COinS